E-LIB Suche - Ergebnisse für: Garrison Jr., Louis P.

1

New Vaccine Platforms—Novel Dimensions of Economic and Soci..:

Buck, Philip O. ; Gomes, Dumingu Aparna ; Beck, Ekkehard...
Vaccines. 12 (2024) 3 - p. 234 , 2024

Link: https://doi.org/10.3390/..

2

Evaluating Policies of Expanding Versus Restricting First-L..:

Jiao, Boshen ; Carlson, Josh J. ; Garrison Jr., Louis P..
Value in Health. 27 (2024) 4 - p. 433-440 , 2024

Link: https://doi.org/10.1016/..

3

Multicriteria Decision Analysis and Value Assessment Framew..:

Garrison Jr, Louis P.
Value in Health. 27 (2024) 1 - p. 3-6 , 2024

Link: https://doi.org/10.1016/..

4

Estimating the Allocation of the Economic Value Generated b..:

Garrison Jr., Louis P. ; Jiao, Boshen ; Elsisi, Zizi...
Value in Health. 27 (2024) 8 - p. 1021-1029 , 2024

Link: https://doi.org/10.1016/..

5

Is the price right? Paying for value today to get more valu..:

Ramagopalan, Sreeram V. ; Diaz, Jose ; Mitchell, Grace..
BMC Medicine. 22 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

6

Does real option value influence oncologists' treatment rec..:

Li, Meng ; Elsisi, Zizi ; Wong, William...
Value in Health. , 2024

Link: https://doi.org/10.1016/..

7

Value-Based Pricing for Patent-Protected Medicines Over the..:

Garrison Jr., Louis P. ; Jiao, Boshen ; Dabbous, Omar
Value in Health. 26 (2023) 3 - p. 336-343 , 2023

Link: https://doi.org/10.1016/..

8

A review of economic issues for gene‐targeted therapies: Va..:

Garrison Jr, Louis P. ; Lo, Andrew W. ; Finkel, Richard S..
American Journal of Medical Genetics Part C: Seminars in Medical Genetics. 193 (2023) 1 - p. 64-76 , 2023

Link: https://doi.org/10.1002/..

9

Estimating the Potential Economic Impact of Tissue Valve Re..:

Wang, Bruce ; Wu, Elizabeth ; Rassloff, Dirk...
Value in Health Regional Issues. 35 (2023) - p. 19-26 , 2023

Link: https://doi.org/10.1016/..

10

Paying for Kidneys: Reflections on Welfare Economics, Polit..:

Garrison Jr, Louis P.
Value in Health. 25 (2022) 12 - p. 1925-1928 , 2022

Link: https://doi.org/10.1016/..

11

Assessing the Cost-effectiveness of a Hypothetical Disease-..:

Boustani, Malaz ; Doty, Erin G. ; Garrison Jr, Louis P....
Clinical Therapeutics. 44 (2022) 11 - p. 1449-1462 , 2022

Link: https://doi.org/10.1016/..

12

Projecting the Long-term Clinical Value of Mavacamten for t..:

Desai, Nihar ; Xie, Jipan ; Wang, Yan...
Clinical Therapeutics. 44 (2022) 1 - p. 52-66.e2 , 2022

Link: https://doi.org/10.1016/..

13

Modeling the Ex Ante Clinical Real Option Value in an Innov..:

Lee, Woojung ; Wong, William B. ; Kowal, Stacey...
PharmacoEconomics. 40 (2022) 6 - p. 623-631 , 2022

Link: https://doi.org/10.1007/..

14

Should We Pay for Scientific Knowledge Spillovers? The Unde..:

Xie, Richard Z. ; Towse, Adrian ; Garrison Jr., Louis P.
International Journal of Technology Assessment in Health Care. 38 (2022) 1 - p. , 2022

Link: https://doi.org/10.1017/..

15

Cost-effectiveness analysis of pre-ART HIV drug resistance ..:

Duarte, Horacio A. ; Babigumira, Joseph B. ; Enns, Eva A....
EClinicalMedicine. 22 (2020) - p. 100355 , 2020

Link: https://doi.org/10.1016/..